Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

Clinical Oncology

Volumn 8, Issue 3, 1996, Pages 167-175

  Macbeth, F R ^a   Bolger, J J ^b   Hopwood, P ^c   Bleehen, N M ^d   Cartmell, J ^e   Girling, D J ^e   Machin, D ^e   Stephens, R J ^e   Bailey, A J ^e   Clark, P I ^f   Connolly, C K ^f   Hasleton, P S ^f   Moghissi, K ^f   Saunders, M I ^f   Thatcher, N ^f   White, R J ^f  

^a WESTERN INFIRMARY   (United Kingdom)

^b WESTON PARK HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f NONE

Author keywords

Non small cell lung cancer; Quality of life; Radiotherapy; Randomized trial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DAILY LIFE ACTIVITY; DISEASE COURSE; DYSPHAGIA; DYSPNEA; FATIGUE; FEMALE; FITNESS; HUMAN; INOPERABLE CANCER; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; METASTASIS; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD DISEASE; THORAX PAIN; TREATMENT FAILURE;

EID: 0010622331     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(96)80041-0     Document Type: Article

References (27)

1. Medical Research Council Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991;63:265-70.
2. Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992;65:934-41.
3. Macbeth FR, Bolger J. Palliative radiotherapy for bronchial carcinoma: Science or art? [editoria] Clin Oncol 1991;3:245-6.
4. Maher EJ, Timothy A, Squire CJ, et al. Audit: The use of radiotherapy for NSCLC in the UK. Clin Oncol 1993;5:72-9.
5. Stephens R, Gibson D. The impact of clinical trials on the treatment of lung cancer. Clin Oncol 1993;5:211-9.
6. Payne DG. Non-small-cell lung cancer: Should unresectable Stage III patients routinely receive high-dose radiation therapy? J Clin Oncol 1988;6:552-8.
7. World Health Organization. WHO Handbook for reporting results of cancer treatment. (WHO offset publications no. 48.) Geneva: WHO, 1979.
8. World Health Organization. International Histological Classification of Tumours: No. 1. Histological typing of lung tumours. 2nd ed. Geneva: WHO, 1981.
9. De Haes JCJ, Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990;62:1034-8.
10. Zigmond AS, Snaith RR. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
11. Fayers PM, Bleehen NM, Girling DJ, et al. Assessment of quality of life in small-cell lung cancer using a daily diary card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer 1991;64:299-306.
12. Hopwood P, Stephens RJ, Machin D. Approaches to the analysis of quality of life data: Experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 1994;3:339-52.
13. Frith L. Quality of life as assessed by the Rotterdam Symptom Checklist in patients with lung cancer [thesis]. Southampton: University of Southampton, 1992.
14. COMPACT Steering Committee. Improving the quality of clinical trials in cancer. Br J Cancer 1991;63:412-5.
15. Thomas JStJ. Lamb D, Ashcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax 1993;48:1135-9.
16. Perez CA, Stanley K, Grundy G, et al. Impact of irradiation technique and tumor extent on tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the Radiation Therapy Oncology Group. Cancer 1982;50:1091-9.
17. Van Houtte P, Rocmans P, Smets P, et al. Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980;6:983-6.
18. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected Stage II and Stage III epidermoid cancer of the lung. N Engl J Med 1986;315:1377-81.
19. Israel L, Bonadonna G, Sylvester R, and members of the EORTC Lung Cancer Group. Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy, and chemoimmunotherapy in operable squamous carcinoma of the lung. In: Muggia FM, Rozencweig M, editors. Lung cancer: Progress in therapeutic research. New York: Raven, 1979:443-52.
20. Medical Research Council Lung Cancer Working Party. The role of post-operative radiotherapy in non-small cell lung cancer; A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Br J Cancer (in press).
21. Macbeth FR, Wheldon TE, Stephens RJ, on behalf of the MRC Lung Cancer Working Party. Radiotherapy-induced dysphagia as a consequence of epithelial cell depletion: A radiobiological model with hierarchical structure [abstract]. Br J Cancer 1995;72(Suppl XXV):15.
22. Macbeth FR, Wheldon TE, Girling DJ, et al., for the Medical Research Council Lung Cancer Working Party. Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol 1996;8:176-81.
23. Hopwood P, Stephens RJ, on behalf of the Medical Research Council (MRC) Lung Cancer Working Party (LCWP). Symptoms at presentation for treatment in patients with lung cancer: Implications for the evaluation of palliative treatment. Br J Cancer 1995;71:633-6.
24. Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or patient? Br J Cancer 1988;57:109-12.
25. Stephens RJ, for the British Medeical Research Council (MRC) Lung Cancer Working Party (LCWP). Quality of life (QL) in randomised clinical trials: Are the doctors' assessments as valid as the patients'? [abstract] Lung Cancer 1994;11(Suppl 1):81.
26. Stephens RJ, Hopwood P. Defining and analysing the palliation of physical symptoms: A deceptively difficult exercise [abstract]. Palliat Med 1995;9:63.
27. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899-909.